- Report
- August 2025
- 150 Pages
Global
From €3012EUR$3,358USD£2,655GBP
€3543EUR$3,950USD£3,124GBP
- Report
- September 2025
- 112 Pages
Global
From €3500EUR$4,180USD£3,194GBP
- Report
- March 2025
- 81 Pages
Global
From €3500EUR$4,180USD£3,194GBP
- Report
- October 2025
- 163 Pages
Global
From €3500EUR$4,180USD£3,194GBP
- Report
- May 2025
- 85 Pages
United States
From €3139EUR$3,500USD£2,768GBP
- Report
- February 2020
- 360 Pages
Global
From €4394EUR$4,899USD£3,874GBP
- Report
- July 2022
- 263 Pages
Global
From €1800EUR$2,150USD£1,642GBP
- Report
- June 2024
- 286 Pages
Global
From €5107EUR$5,893USD£4,350GBP
- Report
- September 2023
- 249 Pages
Global
From €4637EUR$5,351USD£3,950GBP
- Report
- October 2021
- 433 Pages
Global
From €2250EUR$2,687USD£2,053GBP
- Report
- August 2023
- 267 Pages
Global
From €2150EUR$2,568USD£1,962GBP
- Report
- May 2022
- 32 Pages
Global
From €400EUR$478USD£365GBP
- Report
- November 2024
- 240 Pages
Global
From €2153EUR$2,400USD£1,898GBP
- Report
- November 2024
- 600 Pages
Global
From €2960EUR$3,300USD£2,610GBP
- Report
- September 2024
- 210 Pages
Global
From €2153EUR$2,400USD£1,898GBP
- Report
- August 2024
- 195 Pages
Global
From €2153EUR$2,400USD£1,898GBP
- Report
- December 2023
- 220 Pages
Global
From €2960EUR$3,300USD£2,610GBP
- Report
- June 2022
- 1500 Pages
Global
From €3498EUR$3,900USD£3,084GBP
- Drug Pipelines
- May 2022
- 400 Pages
Global
From €2691EUR$3,000USD£2,372GBP
- Report
- November 2024
- 256 Pages
Global
From €3229EUR$3,600USD£2,847GBP
€4036EUR$4,500USD£3,558GBP

Cancer Immunotherapy is a type of Immune Disorders Drugs that uses the body's own immune system to fight cancer. It works by stimulating the body's natural defense system to recognize and attack cancer cells. This type of therapy is used to treat a variety of cancers, including melanoma, lymphoma, and leukemia. It can also be used to treat other types of cancer, such as breast, lung, and colorectal cancer.
Cancer Immunotherapy is a rapidly growing field, with many new treatments being developed. It is an important part of the overall cancer treatment landscape, as it can provide a more targeted approach to treating cancer. It can also be used in combination with other treatments, such as chemotherapy and radiation therapy, to improve outcomes.
Some of the companies in the Cancer Immunotherapy market include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Roche. These companies are developing a range of treatments, including monoclonal antibodies, vaccines, and cell-based therapies. Show Less Read more